KK
RXRX icon

KLP Kapitalforvaltning’s Recursion Pharmaceuticals RXRX Stock Holding History

KLP Kapitalforvaltning’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Buy
97,500
+19,300
+25% +$74.6K ﹤0.01% 1666
2025
Q4 		$320K Buy
78,200
+5,200
+7% +$25.8K ﹤0.01% 1636
2025
Q3 		$356K Buy
73,000
+11,800
+19% +$62K ﹤0.01% 1571
2025
Q2 		$310K Buy
61,200
+10,000
+20% +$49.1K ﹤0.01% 1592
2025
Q1 		$271K Hold
51,200
– – ﹤0.01% 1609
2024
Q4 		$346K Buy
+51,200
New +$344K ﹤0.01% 1568

Other funds holding RXRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return